Misc. Skin and Mucous Drugs

Hypersensitivity to tazarotene or any component of the formulation; Pregency women.

X

尚未建立

>10%:Dermatologic: Burning sensation of skin, desquamation, erythema of skin, exacerbation of psoriasis, pruritus, skin irritation, skin pain, stinging of the skin, xerodermaLocal: Application-site irritation1% to 10%:Cardiovascular: Peripheral edemaDermatologic: Contact dermatitis, dermal hemorrhage, dermatitis, eczema, skin discoloration, skin fissure, skin rashEndocrine & metabolic: HypertriglyceridemiaLocal: Application-site reaction (including application-site dermatitis, application-site edema, application-site erythema, application-site itching, application-site pain, application-site rash, exfoliation of skin, local discomfort, local dryness of skin, local skin discoloration, skin photosensitivity), localized edemaNervous system: Facial pain<1%: Dermatologic: Impetigo

Apply once daily in the evening to psoriatic lesions using enough (2 mg/cm2) to cover only the lesion with a thin film.

Safety data has not been established for use in patients under 12 years of age.

There are no dosage adjustments provided in the manufacturer's labeling.

There are no dosage adjustments provided in the manufacturer's labeling.

Store in a sealed container below 25°C.